Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Artuso

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Italian Journal of Surgical Sciences|January 1, 1989
Pheochromocytoma during pregnancyR Armaroli, S Simoni, S Artuso, et al.
Il Giornale Di Chirurgia|January 1, 1988
[Desmoid tumors]R Armaroli, F Martuzzi, S Artuso, et al.
Minerva Anestesiologica|September 1, 1990
[Follow-up of respiratory function in patients after thoracic surgery]G Gambale, M Vinelli, D De Gasperi, et al.
Journal of Biomedical Nanotechnology|June 16, 2016
Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma GrowthG Salzano, S Zappavigna, A Luce, et al.
Frontiers in Pharmacology|April 10, 2023
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life studyA Iurlo, D Cattaneo, D Consonni, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Italian Journal of Surgical Sciences|January 1, 1989
Pheochromocytoma during pregnancyR Armaroli, S Simoni, S Artuso, et al.
Il Giornale Di Chirurgia|January 1, 1988
[Desmoid tumors]R Armaroli, F Martuzzi, S Artuso, et al.
Minerva Anestesiologica|September 1, 1990
[Follow-up of respiratory function in patients after thoracic surgery]G Gambale, M Vinelli, D De Gasperi, et al.
Journal of Biomedical Nanotechnology|June 16, 2016
Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma GrowthG Salzano, S Zappavigna, A Luce, et al.
Frontiers in Pharmacology|April 10, 2023
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life studyA Iurlo, D Cattaneo, D Consonni, et al.
Pageof 1